Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,165

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Cushing's syndrome

Newell-Price, John, Bertagna, Xavier, Grossman, Ashley B, Nieman, Lynnette K·2006·The Lancet
DOI 10.1016/s0140-6736(06)68699-6
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(06)68699-6

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 172

  1. Newell-Price, 1998, The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states, Endocr Rev, 19, 647
  2. Lindholm, 2001, Incidence and late prognosis of Cushing's syndrome: a population-based study, J Clin Endocrinol Metab, 86, 117
  3. Etxabe, 1994, Morbidity and mortality in Cushing's disease: an epidemiological approach, Clin Endocrinol (Oxf), 40, 479, 10.1111/j.1365-2265.1994.tb02486.x · DOI · Paper page
  4. Ambrosi, 1990, Screening tests for Cushing's syndrome, Clin Endocrinol (Oxf), 33, 809
  5. Contreras, 2000, Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients, Medicina (B Aires), 60, 326
  6. Ilias, 2005, Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health, J Clin Endocrinol Metab, 90, 4955, 10.1210/jc.2004-2527 · DOI · Paper page
  7. Isidori, 2006, The ectopic adrenocorticotrophin syndrome: clinical features, diagnosis, management and long-term follow-up, J Clin Endocrinol Metab, 91, 371, 10.1210/jc.2005-1542 · DOI · Paper page
  8. Wajchenberg, 1994, Ectopic adrenocorticotropic hormone syndrome, Endocr Rev, 15, 752, 10.1210/edrv-15-6-752 · DOI · Paper page
  9. Lacroix, 2001, Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome, Endocr Rev, 22, 75
  10. Dahia, 1999, The molecular pathogenesis of corticotroph tumors, Endocr Rev, 20, 136, 10.1210/edrv.20.2.0358 · DOI
  11. Lidhar, 1999, Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors, J Clin Endocrinol Metab, 84, 3823, 10.1210/jcem.84.10.6066 · doi:10.1210/jcem.84.10.6066
  12. Jordan, 2000, Cyclin D and cyclin E expression in normal and adenomatous pituitary, Eur J Endocrinol, 143, R1, 10.1530/eje.0.143R001 · DOI
  13. Storr, 2004, Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis, J Clin Endocrinol Metab, 89, 3818, 10.1210/jc.2003-031531 · DOI
  14. Woo, 2005, Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas, J Clin Endocrinol Metab, 90, 4963, 10.1210/jc.2005-0070 · DOI
  15. Gibson, 1996, Impaired processing of proopiomelanocortin in corticotroph macroadenomas, J Clin Endocrinol Metab, 81, 497
  16. Ray, 1995, Elevated levels of adrenocorticotropin (ACTH) precursors in post-adrenalectomy Cushing's disease and their regulation by glucocorticoids, J Clin Endocrinol Metab, 80, 2430
  17. Raffin-Sanson, 2003, Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions, Eur J Endocrinol, 149, 79, 10.1530/eje.0.1490079 · DOI · Paper page
  18. Kaye, 1990, The Cushing syndrome: an update on diagnostic tests, Ann Intern Med, 112, 434, 10.7326/0003-4819-76-3-112-6-434 · DOI · Paper page
  19. Korbonits, 2001, Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors, J Clin Endocrinol Metab, 86, 2728
  20. Morris, 2003, Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas, J Clin Endocrinol Metab, 88, 6080, 10.1210/jc.2002-022048 · DOI
  21. Dahia, 1996, Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors, J Clin Endocrinol Metab, 81, 1768
  22. de Keyzer, 1996, The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome, J Clin Invest, 97, 1311, 10.1172/JCI118547 · DOI
  23. Picon, 1995, Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79, J Mol Endocrinol, 15, 187, 10.1677/jme.0.0150187 · DOI
  24. Picon, 1999, Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors, Oncogene, 18, 2627, 10.1038/sj.onc.1202635 · DOI
  25. Newell-Price, 2001, The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression, Mol Endocrinol, 15, 338, 10.1210/mend.15.2.0599 · DOI
  26. Pascual-Le Tallec, 2002, Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors, J Clin Endocrinol Metab, 87, 5015, 10.1210/jc.2002-020598 · DOI
  27. Chabre, 1998, Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis, J Clin Endocrinol Metab, 83, 3134
  28. Lacroix, 1992, Gastric inhibitory polypeptide-dependent cortisol hypersecretion—a new cause of Cushing's syndrome, N Engl J Med, 327, 974, 10.1056/NEJM199210013271402 · DOI · Paper page
  29. Lebrethon, 1998, Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients, J Clin Endocrinol Metab, 83, 4514
  30. N'Diaye, 1998, Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome, J Clin Endocrinol Metab, 83, 2781, 10.1210/jc.83.8.2781 · DOI
  31. Horiba, 1995, Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia, J Clin Endocrinol Metab, 80, 2336
  32. Arnaldi, 1998, Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors, J Clin Endocrinol Metab, 83, 2029
  33. Perraudin, 1995, Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies, J Clin Endocrinol Metab, 80, 2661
  34. Lacroix, 1997, Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension, J Clin Endocrinol Metab, 82, 2414
  35. Mircescu, 2000, Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?, J Clin Endocrinol Metab, 85, 3531
  36. Willenberg, 1998, Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome, N Engl J Med, 339, 27, 10.1056/NEJM199807023390105 · DOI
  37. Pralong, 1999, Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion, J Clin Endocrinol Metab, 84, 3817
  38. Bertherat, 2005, In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism, J Clin Endocrinol Metab, 90, 1302, 10.1210/jc.2004-1256 · DOI
  39. Bourdeau, 2001, Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome, J Clin Endocrinol Metab, 86, 5534
  40. Mazzuco, 2006, Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model, Endocrinology, 147, 782, 10.1210/en.2005-0921 · DOI
  41. Groussin, 2002, The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors, J Clin Endocrinol Metab, 87, 1980, 10.1210/jcem.87.5.8458 · DOI
  42. Swords, 2005, The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?, J Clin Endocrinol Metab, 90, 3009, 10.1210/jc.2004-0946 · DOI
  43. Swords, 2002, Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity, Mol Endocrinol, 16, 2746, 10.1210/me.2002-0099 · DOI
  44. Storr, 2004, Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia, Clin Endocrinol (Oxf), 61, 553, 10.1111/j.1365-2265.2004.02124.x · DOI
  45. Stratakis, 2001, Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation, J Clin Endocrinol Metab, 86, 4041, 10.1210/jcem.86.9.7903 · doi:10.1210/jcem.86.9.7903 · Paper page
  46. Casey, 2000, Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex, J Clin Invest, 106, R31, 10.1172/JCI10841 · DOI · Paper page
  47. Groussin, 2002, Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease, J Clin Endocrinol Metab, 87, 4324, 10.1210/jc.2002-020592 · DOI · Paper page
  48. Bourdeau, 2003, Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor, J Clin Endocrinol Metab, 88, 3931, 10.1210/jc.2002-022001 · DOI
  49. Weinstein, 1991, Activating mutations of the stimulatory G protein in the McCune-Albright syndrome, N Engl J Med, 325, 1688, 10.1056/NEJM199112123252403 · DOI · Paper page
  50. Fragoso, 2003, Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene, J Clin Endocrinol Metab, 88, 2147, 10.1210/jc.2002-021362 · DOI · Paper page
  51. Bertherat, 2003, Molecular and functional analysis of PRKAR1A and its locus (17q22–24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity, Cancer Res, 63, 5308
  52. Gicquel, 2001, Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors, Cancer Res, 61, 6762
  53. Giordano, 2003, Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis, Am J Pathol, 162, 521, 10.1016/S0002-9440(10)63846-1 · DOI · Paper page
  54. Latronico, 2001, An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors, J Clin Endocrinol Metab, 86, 4970, 10.1210/jcem.86.10.7957 · DOI · Paper page
  55. Ribeiro, 2001, An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma, Proc Natl Acad Sci USA, 98, 9330, 10.1073/pnas.161479898 · DOI · Paper page
  56. Davies, 2005, Final adult height and body mass index after cure of paediatric Cushing's disease, Clin Endocrinol (Oxf), 62, 466, 10.1111/j.1365-2265.2005.02244.x · DOI
  57. Savage, 2001, Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome, Horm Res, 55, 24, 10.1159/000063459 · DOI
  58. Savage, 2001, Growth abnormalities associated with adrenal disorders and their management, Horm Res, 56, 19, 10.1159/000048129 · DOI
  59. Weber, 1995, Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome, Clin Endocrinol (Oxf), 43, 19, 10.1111/j.1365-2265.1995.tb01888.x · DOI
  60. Faggiano, 2003, Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure, J Clin Endocrinol Metab, 88, 2076, 10.1210/jc.2002-021494 · DOI
  61. Di Somma, 2002, Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease, Clin Endocrinol (Oxf), 56, 153, 10.1046/j.0300-0664.2001.01454.doc.x · DOI
  62. Scommegna, 2005, Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease, J Endocrinol Invest, 28, 231, 10.1007/BF03345378 · DOI
  63. Minetto, 2004, Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome, Osteoporos Int, 15, 855, 10.1007/s00198-004-1616-3 · DOI
  64. Ohmori, 2003, Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome, Endocr J, 50, 1, 10.1507/endocrj.50.1 · DOI · Paper page
  65. Forget, 2002, Persistent cognitive impairment following surgical treatment of Cushing's syndrome, Psychoneuroendocrinology, 27, 367, 10.1016/S0306-4530(01)00059-2 · DOI
  66. Bourdeau, 2002, Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism, J Clin Endocrinol Metab, 87, 1949
  67. Heald, 2004, Long-term negative impact on quality of life in patients with successfully treated Cushing's disease, Clin Endocrinol (Oxf), 61, 458, 10.1111/j.1365-2265.2004.02118.x · DOI · Paper page
  68. van Aken, 2005, Quality of life in patients after long-term biochemical cure of Cushing's disease, J Clin Endocrinol Metab, 90, 3279, 10.1210/jc.2004-1375 · DOI · Paper page
  69. Zacharieva, 2005, Markers of vascular function in hypertension due to Cushing's syndrome, Horm Metab Res, 37, 36, 10.1055/s-2005-861031 · DOI
  70. Terzolo, 2004, Hyperhomocysteinemia in patients with Cushing's syndrome, J Clin Endocrinol Metab, 89, 3745, 10.1210/jc.2004-0079 · DOI
  71. Rockall, 2003, Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography, Eur J Endocrinol, 149, 543, 10.1530/eje.0.1490543 · DOI · Paper page
  72. Rockall, 2003, Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome, Eur J Endocrinol, 149, 561, 10.1530/eje.0.1490561 · DOI
  73. Lindsay, 2005, Cushing's syndrome during pregnancy: personal experience and review of the literature, J Clin Endocrinol Metab, 90, 3077, 10.1210/jc.2004-2361 · DOI · Paper page
  74. Lindsay, 2005, The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment, Endocr Rev, 26, 775, 10.1210/er.2004-0025 · DOI · Paper page
  75. Yanovski, 1994, Glucocorticoid action and the clinical features of Cushing's syndrome, Endocrinol Metab Clin North Am, 23, 487, 10.1016/S0889-8529(18)30080-X · DOI
  76. Putignano, 1998, The effects of anti-convulsant drugs on adrenal function, Horm Metab Res, 30, 389, 10.1055/s-2007-978903 · DOI
  77. Isidori, 2003, Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome, J Clin Endocrinol Metab, 88, 5299, 10.1210/jc.2003-030510 · DOI
  78. Newell-Price, 1995, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome, Clin Endocrinol (Oxf), 43, 545, 10.1111/j.1365-2265.1995.tb02918.x · DOI · Paper page
  79. Papanicolaou, 1998, A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states, J Clin Endocrinol Metab, 83, 1163
  80. Reimondo, 2005, Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome, Eur J Endocrinol, 153, 803, 10.1530/eje.1.02042 · DOI
  81. Castro, 1999, Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests, J Clin Endocrinol Metab, 84, 878
  82. Gafni, 2000, Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents, J Pediatr, 137, 30, 10.1067/mpd.2000.106226 · DOI
  83. Papanicolaou, 2002, Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome, J Clin Endocrinol Metab, 87, 4515, 10.1210/jc.2002-020534 · DOI · Paper page
  84. Castro, 2003, A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome, Clin Endocrinol (Oxf), 59, 800, 10.1046/j.1365-2265.2003.01908.x · DOI
  85. Viardot, 2005, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism as compared to urinary free cortisol and overnight dexamethasone suppression test, J Clin Endocrinol Metab, 90, 5730, 10.1210/jc.2004-2264 · DOI · Paper page
  86. Yanovski, 1998, The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology, J Clin Endocrinol Metab, 83, 348
  87. Yanovski, 1993, Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration: a new test to distinguish Cushing's syndrome from pseudo-Cushing's states, JAMA, 269, 2232, 10.1001/jama.1993.03500170062035 · DOI · Paper page
  88. Coiro, 2000, Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome, J Intern Med, 247, 667, 10.1046/j.1365-2796.2000.00676.x · DOI
  89. Moro, 2000, The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states, J Clin Endocrinol Metab, 85, 3569
  90. Invitti, 1999, Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis, J Clin Endocrinol Metab, 84, 440
  91. Rockall, 2004, CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome, Radiographics, 24, 435, 10.1148/rg.242035092 · DOI
  92. Stewart, 1995, 11 beta-hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome, J Clin Endocrinol Metab, 80, 3617
  93. Aron, 1997, Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome, J Clin Endocrinol Metab, 82, 1780
  94. Nieman, 1993, A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome, J Clin Endocrinol Metab, 77, 1308
  95. Reimondo, 2003, The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome, Clin Endocrinol (Oxf), 58, 718, 10.1046/j.1365-2265.2003.01776.x · DOI
  96. Newell-Price, 2002, Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome, J Clin Endocrinol Metab, 87, 1640
  97. Arlt, 1997, Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in vivo and in vitro, Clin Endocrinol (Oxf), 47, 623, 10.1046/j.1365-2265.1997.3091129.x · DOI
  98. de Keyzer, 1997, V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors, Horm Res, 47, 259, 10.1159/000185473 · DOI
  99. Newell-Price, 1997, The desmopressin test and Cushing's syndrome: current state of play, Clin Endocrinol (Oxf), 47, 173
  100. Tsagarakis, 2002, The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion, J Clin Endocrinol Metab, 87, 1646
  101. Newell-Price, 1997, A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome, J Clin Endocrinol Metab, 82, 176
  102. Tsagarakis, 2000, The application of a combined stimulation with CRH and desmopressin during bilateral inferior petrosal sinus sampling in patients with Cushing's syndrome, Clin Endocrinol (Oxf), 52, 355, 10.1046/j.1365-2265.2000.00943.x · DOI
  103. Oldfield, 1991, Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome, N Engl J Med, 325, 897, 10.1056/NEJM199109263251301 · DOI · Paper page
  104. Lindsay, 2005, Differential diagnosis and imaging in Cushing's syndrome, Endocrinol Metab Clin North Am, 34, 403, 10.1016/j.ecl.2005.01.009 · DOI
  105. Swearingen, 2004, Diagnostic errors after inferior petrosal sinus sampling, J Clin Endocrinol Metab, 89, 3752, 10.1210/jc.2003-032249 · DOI · Paper page
  106. McNally, 1993, Preliminary observations using endocrine markers of pituitary venous dilution during bilateral simultaneous inferior petrosal sinus catheterization in Cushing's syndrome: is combined CRF and TRH stimulation of value?, Clin Endocrinol (Oxf), 39, 681, 10.1111/j.1365-2265.1993.tb02427.x · DOI
  107. Findling, 2004, Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent, J Clin Endocrinol Metab, 89, 6005, 10.1210/jc.2004-1378 · DOI
  108. Lienhardt, 2001, Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome, J Clin Endocrinol Metab, 86, 5711
  109. Liu, 2004, Cavernous and inferior petrosal sinus sampling in the evaluation of ACTH-dependent Cushing's syndrome, Clin Endocrinol (Oxf), 61, 478, 10.1111/j.1365-2265.2004.02115.x · DOI
  110. Erickson, 2004, Internal jugular vein sampling in adrenocorticotropic hormone-dependent Cushing's syndrome: a comparison with inferior petrosal sinus sampling, Clin Endocrinol (Oxf), 60, 413, 10.1111/j.1365-2265.2004.01990.x · DOI
  111. Ilias, 2004, Jugular venous sampling: an alternative to petrosal sinus sampling for the diagnostic evaluation of adrenocorticotropic hormone-dependent Cushing's syndrome, J Clin Endocrinol Metab, 89, 3795, 10.1210/jc.2003-032014 · DOI
  112. Sohaib, 1999, CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome, Am J Roentgenol, 172, 997, 10.2214/ajr.172.4.10587135 · DOI
  113. Patronas, 2003, Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors, J Clin Endocrinol Metab, 88, 1565, 10.1210/jc.2002-021438 · DOI · Paper page
  114. Batista, 2005, Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease, J Clin Endocrinol Metab, 90, 5134, 10.1210/jc.2004-1778 · DOI
  115. Hall, 1994, Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population, Ann Intern Med, 120, 817, 10.7326/0003-4819-120-10-199405150-00001 · DOI · Paper page
  116. Lamberts, 1994, A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome, J Clin Endocrinol Metab, 78, 17
  117. Phlipponneau, 1994, Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor, J Clin Endocrinol Metab, 78, 20
  118. Granberg, 2003, Octreoscan in patients with bronchial carcinoid tumours, Clin Endocrinol (Oxf), 59, 793, 10.1046/j.1365-2265.2003.01931.x · DOI
  119. Tsagarakis, 2003, A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome, J Clin Endocrinol Metab, 88, 4754, 10.1210/jc.2003-030525 · DOI
  120. Pacak, 2004, The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome, J Clin Endocrinol Metab, 89, 2214, 10.1210/jc.2003-031812 · DOI
  121. Orlefors, 2005, Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography, J Clin Endocrinol Metab, 90, 3392, 10.1210/jc.2004-1938 · DOI · Paper page
  122. Nieman, 2002, Medical therapy of Cushing's disease, Pituitary, 5, 77, 10.1023/A:1022308429992 · DOI · Paper page
  123. Aniszewski, 2001, Cushing syndrome due to ectopic adrenocorticotropic hormone secretion, World J Surg, 25, 934, 10.1007/s00268-001-0032-5 · DOI · Paper page
  124. Krakoff, 2001, Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome, J Clin Endocrinol Metab, 86, 4104
  125. Drake, 1998, Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis, J Clin Endocrinol Metab, 83, 3542
  126. Greening, 2005, Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease, Horm Res, 64, 140, 10.1159/000088587 · DOI
  127. Reznik, 1992, Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide, N Engl J Med, 327, 981, 10.1056/NEJM199210013271403 · DOI · Paper page
  128. Heaney, 2002, Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas, Nat Med, 8, 1281, 10.1038/nm784 · DOI · Paper page
  129. Heaney, 2003, PPAR-gamma receptor ligands: novel therapy for pituitary adenomas, J Clin Invest, 111, 1381, 10.1172/JCI200316575 · DOI
  130. Cannavo, 2005, Effectiveness of long-term rosiglitazone administration in patients with Cushing's disease, Clin Endocrinol (Oxf), 63, 118, 10.1111/j.1365-2265.2005.02285.x · DOI
  131. Ambrosi, 2004, Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease, Eur J Endocrinol, 151, 173, 10.1530/eje.0.1510173 · DOI
  132. Suri, 2005, Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease, J Clin Endocrinol Metab, 90, 1340, 10.1210/jc.2004-1746 · DOI
  133. Pivonello, 2004, Dopamine receptor expression and function in corticotroph pituitary tumors, J Clin Endocrinol Metab, 89, 2452, 10.1210/jc.2003-030837 · DOI · Paper page
  134. Hofland, 2005, The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5, Eur J Endocrinol, 152, 645, 10.1530/eje.1.01876 · DOI · Paper page
  135. Pivonello, 2005, Cabergoline plus lanreotide for ectopic Cushing's syndrome, N Engl J Med, 352, 2457, 10.1056/NEJM200506093522322 · DOI
  136. Paez-Pereda, 2001, Retinoic acid prevents experimental Cushing syndrome, J Clin Invest, 108, 1123, 10.1172/JCI11098 · DOI · Paper page
  137. Benbassat, 2004, [Cushing disease: long-term follow-up after transsphenoidal surgery], Harefuah, 143, 636
  138. Chee, 2001, Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?, Clin Endocrinol (Oxf), 54, 617, 10.1046/j.1365-2265.2001.01261.x · DOI · Paper page
  139. Colombo, 2000, Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease, Eur J Endocrinol, 143, 227, 10.1530/eje.0.1430227 · DOI
  140. Dall'Asta, 2005, Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test, Pituitary, 10.1007/s11102-005-0425-9 · DOI
  141. Estrada, 2001, The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease, J Clin Endocrinol Metab, 86, 5695
  142. Hague, 2000, Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease, Surg Neurol, 53, 77, 10.1016/S0090-3019(99)00159-7 · DOI
  143. Hammer, 2004, Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results, J Clin Endocrinol Metab, 89, 6348, 10.1210/jc.2003-032180 · DOI · Paper page
  144. Pereira, 2003, Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease, J Clin Endocrinol Metab, 88, 5858, 10.1210/jc.2003-030751 · DOI · Paper page
  145. Pimentel-Filho, 2005, Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively, J Endocrinol Invest, 28, 502, 10.1007/BF03347237 · DOI
  146. Rees, 2002, Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission, Clin Endocrinol (Oxf), 56, 541, 10.1046/j.1365-2265.2002.01511.x · DOI · Paper page
  147. Rollin, 2004, Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease, J Clin Endocrinol Metab, 89, 1131, 10.1210/jc.2003-031170 · DOI
  148. Salenave, 2004, Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas, J Clin Endocrinol Metab, 89, 3371, 10.1210/jc.2003-031908 · DOI
  149. Sheehan, 2000, Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor, Neurosurgery, 47, 33
  150. Shimon, 2002, Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients, Neurosurgery, 51, 57, 10.1097/00006123-200207000-00008 · DOI
  151. Valero, 2004, The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease, Eur J Endocrinol, 151, 727, 10.1530/eje.0.1510727 · DOI
  152. Yap, 2002, Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit, Clin Endocrinol (Oxf), 56, 25, 10.1046/j.0300-0664.2001.01444.x · DOI · Paper page
  153. Atkinson, 2005, Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance, Clinical Endocrinol (Oxf), 63, 549, 10.1111/j.1365-2265.2005.02380.x · DOI · Paper page
  154. Trainer, 1993, Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment, Clin Endocrinol (Oxf), 38, 73, 10.1111/j.1365-2265.1993.tb00975.x · DOI · Paper page
  155. Locatelli, 2005, Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease, J Clin Endocrinol Metab, 90, 5478, 10.1210/jc.2004-2436 · DOI
  156. Brunt, 2001, Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors, Surgery, 130, 629, 10.1067/msy.2001.116920 · DOI
  157. Chavez-Rodriguez, 2005, Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series, Am J Surg, 189, 581, 10.1016/j.amjsurg.2005.02.003 · DOI
  158. Iacobone, 2005, Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients, J Endocrinol Invest, 28, 327, 10.1007/BF03347198 · DOI
  159. Meyer, 2004, Cushing's syndrome: adrenalectomy and long-term results, Dig Surg, 21, 363, 10.1159/000081353 · DOI
  160. O'Boyle, 2003, Laparoscopic transperitoneal adrenalectomy, Surg Endosc, 17, 1905, 10.1007/s00464-002-8878-7 · DOI
  161. Porpiglia, 2004, Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery, J Endocrinol Invest, 27, 654, 10.1007/BF03347498 · DOI
  162. Poulose, 2005, Laparoscopic adrenalectomy: 100 resections with clinical long-term follow-up, Surg Endosc, 19, 379, 10.1007/s00464-004-8914-x · DOI
  163. Vella, 2001, Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome, J Clin Endocrinol Metab, 86, 1596
  164. Zeh, 2003, One hundred laparoscopic adrenalectomies: a single surgeon's experience, Ann Surg Oncol, 10, 1012, 10.1245/ASO.2003.06.001 · DOI
  165. Dackiw, 2001, Adrenal cortical carcinoma, World J Surg, 25, 914, 10.1007/s00268-001-0030-7 · DOI · Paper page
  166. Assie, 2004, The Nelson's syndrome revisited, Pituitary, 7, 209, 10.1007/s11102-005-1403-y · DOI
  167. Kelly, 2002, Neurosurgical treatment of Nelson's syndrome, J Clin Endocrinol Metab, 87, 5465, 10.1210/jc.2002-020299 · DOI
  168. Jenkins, 1995, The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome, J Clin Endocrinol Metab, 80, 165
  169. Estrada, 1997, The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease, N Engl J Med, 336, 172, 10.1056/NEJM199701163360303 · DOI · Paper page
  170. Storr, 2003, Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment, J Clin Endocrinol Metab, 88, 34, 10.1210/jc.2002-021032 · DOI
  171. Devin, 2004, The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease, Stereotact Funct Neurosurg, 82, 254, 10.1159/000083476 · DOI
  172. Sheehan, 2000, Radiosurgery for Cushing's disease after failed transsphenoidal surgery, J Neurosurg, 93, 738, 10.3171/jns.2000.93.5.0738 · DOI · Paper page

Cited by

See all 1,165

Metadata

Authors
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K.
Venue
The Lancet
Publisher
Elsevier BV
Published
2006-05
Volume
367
Issue
9522
Pages
1605-1617
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(06)68699-6
OpenAlex
W4211186562
Cited by
1,165
References
29
FWCI
30.05
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cushing's syndrome. https://app.cochat.ai/papers/10.1016/s0140-6736(06)68699-6
The paper
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006). Cushing's syndrome. The Lancet. https://doi.org/10.1016/s0140-6736(06)68699-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.